Learning Objectives
Upon completion of this activity, participants should be able to:
- Review recommendations for assessing cardiovascular risk and managing dyslipidemia in HIV-infected patients on HAART
- Describe the impact of switching PIs on dyslipidemia in HIV-infected patients receiving HAART
- Discuss the impact of switching NRTIs on dyslipidemia and lipoatrophy in HIV-infected patients receiving HAART
Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.